Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)
Clinical trial NCT06025812 · UNKNOWN
Trial details
- NCT number
- NCT06025812
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-20
- Primary completion
- 2024-05-15
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.